Literature DB >> 35165123

SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Should We Consider Intradermal Vaccination?

Veerle Wijtvliet1, Karl Martin Wissing2, Daniel Abramowicz3, Kristien J Ledeganck3.   

Abstract

Entities:  

Keywords:  COVID-19; COVID-19 vaccines; SARS-CoV-2; T lymphocytes; intradermal vaccination; kidney transplant recipients; third dose

Mesh：

Substances：

Year:  2022        PMID： 35165123      PMCID： PMC8970452          DOI： 10.1681/ASN.2021121566

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  2 in total

1.  Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.

Authors:  Emmanuel Morelon; Claire Pouteil Noble; Sameh Daoud; Remi Cahen; Catherine Goujon-Henry; Françoise Weber; Philippe E Laurent; Dominique Kaiserlian; Jean-François Nicolas
Journal:  Vaccine       Date:  2010-08-13       Impact factor: 3.641

2.  B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.

Authors:  Eva Schrezenmeier; Hector Rincon-Arevalo; Ana-Luisa Stefanski; Alexander Potekhin; Henriette Straub-Hohenbleicher; Mira Choi; Friederike Bachmann; Vanessa Pross; Charlotte Hammett; Hubert Schrezenmeier; Carolin Ludwig; Bernd Jahrsdörfer; Andreia Lino; Kai-Uwe Eckardt; Katja Kotsch; Thomas Dörner; Klemens Budde; Arne Sattler; Fabian Halleck
Journal:  J Am Soc Nephrol       Date:  2021-10-19       Impact factor: 10.121
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.